Author

Gino B. Ferraro

Harvard UniversityORCID 0000-0002-1587-4259Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Sonu SubudhiiD· 2 shared Ahmed AliiD· 1 shared Alona MuzikanskyiD· 1 shared Anat O Stemmer-RachamimoviD· 1 shared Anna M. BarbeauiD· 1 shared Anna Shevzov-Zebrun· 1 shared Ashwin Srinivasan KumariD· 1 shared Athena Ching‐Jung Wang· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Sonu SubudhiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Site of breast cancer metastasis is independent of single nutrient levels

Keene L. Abbott, Sonu Subudhi, Raphaël Ferreira, Yetiş Gültekin, Sophie Charlotte Steinbuch, Muhammad Bin Munim, Diya L. Ramesh, Sophie Elisabeth Honeder, Ashwin Srinivasan Kumar, Michelle Wu, Jacob Hansen, Anna Shevzov-Zebrun, Edrees H. Rashan, Kian Moritz Eghbalian, Sharanya Sivanand, , Matthew G. Vander Heiden

This study shows that single nutrients do not determine breast cancer metastasis sites, and identifies purine synthesis as a key factor across multiple tissues.

Nature · Jan 7, 2026Peer-reviewedCancer Biology

Co-Targeting IL-6 and EGFR signaling for the treatment of schwannomatosis and associated pain

Zhenzhen Yin, Limeng Wu, Yanling Zhang, Yao Sun, John W. Chen, Sonu Subudhi, William W. Ho, Grace Y. Lee, Athena Ching‐Jung Wang, Xing Gao, Jun P. Ren, Chao Zhu, Na Zhang, Gino B. Ferraro, Alona Muzikansky, , Lei Xu

This study identifies IL-6 and EGFR signaling as therapeutic targets for schwannomatosis, showing combined blockade reduces both pain and tumor growth in preclinical models.

bioRxiv · Feb 6, 2023 · PreprintNeuroscience